BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben-Skowronek I, Sieniawska J, Pach E, Wrobel W, Skowronek A, Tomczyk Z, Rosolowska I. Potential Therapeutic Application of Regulatory T Cells in Diabetes Mellitus Type 1. Int J Mol Sci 2021;23:390. [PMID: 35008819 DOI: 10.3390/ijms23010390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Palianina D, Di Roberto RB, Castellanos-rueda R, Schlatter F, Reddy ST, Khanna N. A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications.. [DOI: 10.1101/2022.10.31.514542] [Reference Citation Analysis]
2 Starosz A, Jamiołkowska-sztabkowska M, Głowińska-olszewska B, Moniuszko M, Bossowski A, Grubczak K. Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children. Front Immunol 2022;13:958430. [DOI: 10.3389/fimmu.2022.958430] [Reference Citation Analysis]